Article
Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis.
Mutagenesis - 1 Sept 2000
Johns L E, Houlston R S
Abstract excerpt
Inter-individual differences in bladder cancer susceptibility may be mediated in part through polymorphic variability in the bioactivation and detoxification of procarcinogens. Glutathione S-transferase mu1 (GSTM1) status has been extensively studied as a risk factor in this context. To clarify the impact of GSTM1 deficiency on bladder cancer risk a meta-analysis of 15 case-control studies from the literature has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
